Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform

Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform SANTA CLARA, Calif., and WINOOSKI, Vt., April 4, 2018 Agilent Technologies Inc. (NYSE: A) and BioTek Instruments, Inc. today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies. The optimized solution integrates the Agilent Seahorse XFe96/XFe24 Analyzers... Read more

PerkinElmer Prices Offering of Euro-Denominated Senior Notes

April 4, 2018 at 4:15 PM EDT PDF Version WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of €300 million aggregate principal amount of 0.600% Senior Notes due 2021 at an issue price of 99.950% of the principal... Read more

Agilent Technologies Signs Agreement to Acquire Lasergen, Inc.

Agilent Technologies Signs Agreement to Acquire Lasergen, Inc. Acquisition affirms Agilent’s strategic intent to grow in the diagnostics space and build a complete routine clinical NGS workflow SANTA CLARA, Calif., April 3, 2018 Agilent Technologies Inc. (NYSE: A) and Lasergen, Inc. (Lasergen) today announced that they have signed a definitive agreement for Agilent to acquire... Read more

Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts

New State-of-the-Art Facility Will Support Continued Growth and Innovation MILFORD, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Following recent approval by its Board of Directors, Waters Corporation (NYSE: WAT) announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as... Read more

Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release

Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release MycoSEQ Mycoplasma Detection Method can accelerate production timelines for manufacturers of cell and gene therapies, biotherapeutics, vaccines and other cell-culture-based modalities BEDFORD, Mass., April 3, 2018 /PRNewswire/ — Manufacturers of cell-culture-based therapeutics can now rely on a faster method for detecting mycoplasma contamination.... Read more

VICAM Introduces a New Method for BPA Detection

BPATest enables food and agricultural laboratories to isolate and purify BPA for analysis in as little as ten minutes MILFORD, Mass.–(BUSINESS WIRE)–Mar. 29, 2018– Waters Corporation (NYSE:WAT) announced VICAM®, a Waters® Business, introduced a sensitive, precise determination of Bisphenol A (BPA) for food and agricultural laboratories. VICAM’s BPATest™ quickly isolates and purifies BPA for analysis from 0.1 to 50 parts... Read more

Thermo Fisher Scientific Sponsors Precision Medicine Summit in China

One-day event in Beijing convened more than 400 leaders from government, academia and industry to discuss precision medicine advancement BEIJING, March 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today sponsored the first China-U.S. Precision Medicine Summit, along with co-hosts CEO Roundtable on Cancer, China Academy of Medical Sciences and... Read more

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif., March 28, 2018 /PRNewswire/ — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled... Read more

New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR

New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR Real-Time PCR workflow gains NF VALIDATION by AFNOR Certification for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, March 27, 2018 /PRNewswire/ — Laboratories performing tests for poultry producers... Read more